Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-007708

Director sold 10,056 shares at $9.45 ($95,063)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCANGOS GEORGE A Director 2025-02-24 Sale 10b5-1 −10,056 $9.45 $95,063 698,239 D
Open-market sales · 10,056 sh · avg $9.45 · $95,063
Loading xslF345X05/wk-form4_1740516289.xml…